A Guerin, L Chen, K Dea, EQ Wu… - Journal of Medical …, 2014 - Taylor & Francis

Economic benefits of adequate molecular monitoring in patients with chronic myelogenous leukemia.

community settings

[No authors listed]

GSID: wFZgrPMrl1gJ

Excerpt

Objective: Molecular monitoring of chronic myeloid leukemia (CML) has been associated with improved clinical outcomes during tyrosine kinase inhibitor therapy (TKI), yet recent …

Cited by

Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in chronic phase after generic entry of imatinib in the United States.

Dusetzina SB, Padula WV.
WV Padula, RA Larson, SB Dusetzina… - Journal of the …, 2016 - academic.oup.com
GSID: PHqsm5jVl-kJ

Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemia.

Goldberg SL.
SL Goldberg, LP Akard, MJ Dugan, S Faderl… - Journal of oncology …, 2015 - ascopubs.org
GSID: GbDzB_rIaHsJ